D.E. Shaw & Co’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-96,796
| Closed | -$773K | – | 3117 |
|
|
2024
Q3 | $773K | Buy |
96,796
+47,837
| +98% | +$382K | ﹤0.01% | 2294 |
|
|
2024
Q2 | $426K | Buy |
+48,959
| New | +$426K | ﹤0.01% | 2570 |
|
|
2024
Q1 | – | Sell |
-100,960
| Closed | -$2.33M | – | 3209 |
|
|
2023
Q4 | $2.33M | Buy |
+100,960
| New | +$2.33M | ﹤0.01% | 1663 |
|
|
2023
Q1 | – | Sell |
-27,025
| Closed | -$94.6K | – | 3387 |
|
|
2022
Q4 | $94.6K | Sell |
27,025
-21,755
| -45% | -$76.1K | ﹤0.01% | 3139 |
|
|
2022
Q3 | $386K | Sell |
48,780
-63,224
| -56% | -$500K | ﹤0.01% | 2985 |
|
|
2022
Q2 | $881K | Sell |
112,004
-49,715
| -31% | -$391K | ﹤0.01% | 2759 |
|
|
2022
Q1 | $1.97M | Sell |
161,719
-116,953
| -42% | -$1.42M | ﹤0.01% | 2444 |
|
|
2021
Q4 | $3.41M | Buy |
278,672
+210,623
| +310% | +$2.58M | ﹤0.01% | 1998 |
|
|
2021
Q3 | $709K | Buy |
68,049
+13,715
| +25% | +$143K | ﹤0.01% | 2667 |
|
|
2021
Q2 | $489K | Buy |
+54,334
| New | +$489K | ﹤0.01% | 2896 |
|